V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240014412 | 240008695 | 1.65 | null | Curative (C) | 2018-01-07 | 2018-01-08 | BEVACIZUMAB + CISPLATIN + PACLITAXEL | N | N | 240010195 | CAV |
| 240014413 | 240012640 | 1.68 | 119 | Palliative (P) | 2015-09-18 | 2015-10-10 | ALL UKALL60+ TRIAL | N | N | 240010288 | VINORELBINE |
| 240014414 | 240016275 | 1.8 | 73.4 | Disease modification (D) | 2019-03-26 | 2019-06-10 | CARMUSTINE + THIOTEPA | Y | N | 240010386 | GEMCITABINE + PACLITAXEL |
| 240014415 | 240016275 | 1.6 | 70.4 | Curative (C) | 2019-04-12 | 2019-07-14 | AML 18 TRIAL | 2 | N | 240010386 | RCEOP |
| 240014416 | 240008698 | 1.83 | 62.7 | Curative (C) | 2014-10-03 | 2014-10-06 | CARMUSTINE + THIOTEPA | 1 | N | 240010430 | R-EPOCH |
| 240014417 | 240008701 | 1.7 | null | Curative (C) | 2019-01-21 | 2019-02-15 | DHAP - R | 1 | null | 240010545 | OSIMERTINIB |
| 240014418 | 240012645 | 1.87 | 112.4 | Palliative (P) | 2017-10-11 | 2018-01-29 | VEDex | null | N | 240010556 | RCEOP |
| 240014419 | 240008704 | 1.52 | 68 | Palliative (P) | 2015-03-03 | 2015-03-10 | TOPOTECAN | N | N | 240010651 | ATG + BUSULFAN + FLUDARABINE + THIOTEPA |
| 240014420 | 240015914 | 1.78 | 75 | Palliative (P) | 2016-08-29 | 2016-09-28 | DA-EPOCH-R | N | N | 240011026 | CYTARABINE + ETOPOSIDE |
| 240014421 | 240016337 | 1.6 | 65 | null | 2016-01-20 | 2016-02-08 | CISPLATIN + FLUOROURACIL | N | N | 240011053 | BORTEZOMIB + RITUXIMAB |
| 240014422 | 240008705 | 1.79 | 75.8 | Palliative (P) | 2017-10-28 | 2017-10-29 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | 240011182 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 240014423 | 240008706 | 1.65 | 62 | Curative (C) | 2014-12-09 | 2015-04-12 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 240011194 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB |
| 240014424 | 240008707 | 1.86 | 67.1 | Curative (C) | 2017-06-19 | 2017-06-19 | R CODOX M | N | N | 240011315 | IVAC |
| 240014425 | 240008708 | 1.65 | 60 | Palliative (P) | 2017-10-26 | 2017-11-03 | PEMBROLIZUMAB | 2 | N | 240011368 | AML18 TRIAL |
| 240014426 | 240008710 | 1.91 | 99.9 | null | 2014-12-12 | 2015-02-28 | Etoposide oral | 02 | null | 240011485 | IVE |
| 240014427 | 240008711 | null | 58.2 | Curative (C) | null | 2018-12-04 | CISPLATIN + FLUOROURACIL + RT | N | null | 240011523 | POMALIDOMIDE |
| 240014428 | 240008714 | 1.77 | null | Disease modification (D) | null | 2017-11-23 | Docetaxel | null | null | 240011523 | CYTARABINE HD + METHOTREXATE HD |
| 240014429 | 240012654 | 1.54 | 62.3 | Curative (C) | 2016-01-31 | 2016-05-08 | ALL UKALL60+ TRIAL | 02 | null | 240011596 | RCEOP |
| 240014430 | 240008717 | 1.84 | 64.1 | Curative (C) | 2015-09-14 | 2016-12-08 | R CODOX M | N | N | 240011643 | FLAG |
| 240014431 | 240008720 | 1.66 | 107.7 | Curative (C) | 2016-11-19 | 2016-11-19 | CARBOPLATIN + VINORELBINE | N | N | 240011697 | RCEOP |
| 240014432 | 240008720 | 1.78 | null | Curative (C) | 2016-08-14 | 2016-08-14 | Cyclophos + Dex + Lenalidomide | 2 | null | 240011697 | ADE |
| 240014433 | 240008722 | 1.71 | 69.9 | Palliative (P) | 2018-03-05 | 2018-03-11 | IVAC | N | N | 240011993 | DHAP - R |
| 240014434 | 240008724 | 1.57 | null | Palliative (P) | null | 2014-10-15 | CISPLATIN + FLUOROURACIL | N | N | 240012059 | CARBOPLATIN + LIPOSOMAL DOX |
| 240014435 | 240008727 | 1.62 | 75.9 | Curative (C) | 2017-06-19 | 2017-06-20 | AML 18 TRIAL | 02 | n | 240012243 | CISPLATIN + FLUOROURACIL |
| 240014436 | 240008728 | 1.87 | 52.1 | Palliative (P) | 2016-06-28 | 2016-06-28 | ETOPOSIDE | 2 | N | 240012266 | DTPACE |
| 240014437 | 240008730 | 1.74 | 85.2 | Disease modification (D) | 2016-03-20 | 2016-08-30 | REMODLB TRIAL | N | N | 240012308 | IVE |
| 240014438 | 240008731 | 1.7 | 76 | Disease modification (D) | 2015-11-14 | 2015-12-14 | CLADRIBINE | 02 | N | 240012317 | GALLIUM TRIAL |
| 240014439 | 240016277 | 1.74 | 59.1 | Palliative (P) | 2018-08-29 | 2018-09-10 | ICE (no GCSF) | Y | N | 240012325 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 240014440 | 240012664 | 1.7 | 84.8 | Curative (C) | 2016-01-30 | 2016-02-26 | CISPLATIN + GEMCITABINE | 01 | N | 240012393 | CYTARABINE INTRATHECAL |
| 240014441 | 240008734 | 1.64 | null | Disease modification (D) | 2017-05-31 | 2018-01-04 | ACE (3 day) | null | N | 240012407 | FAB LMB |
| 240014442 | 240008735 | 1.83 | 59.1 | Disease modification (D) | 2013-11-17 | 2014-01-19 | ICE + GCSF | 02 | N | 240012407 | ICE |
| 240014443 | 240008737 | 1.8 | null | Disease modification (D) | 2017-03-17 | 2017-03-31 | CYTARABINE + RITUXIMAB | N | N | 240012421 | CISPLATIN + GEMCITABINE |
| 240014444 | 240008740 | 1.59 | 57.8 | Disease modification (D) | 2017-05-13 | 2017-05-13 | Cyclophosphamide + Etoposide (PO) | 02 | N | 240012479 | AML18 TRIAL |
| 240014445 | 240008742 | null | 83 | Curative (C) | 2019-01-17 | 2019-01-17 | R CODOX M | 2 | N | 240012886 | CYCLO + FLUDARABINE + RITUXIMAB |
| 240014446 | 240008742 | 1.7 | 90.5 | Disease modification (D) | 2016-05-25 | 2016-07-29 | Ipilimumab | N | N | 240012886 | OFATUMUMAB |
| 240014447 | 240008745 | 1.55 | 51.1 | Curative (C) | 2017-09-04 | 2017-09-10 | CISPLATIN + FLUOROURACIL + RT | N | N | 240013365 | CARBOPLATIN + LIPOSOMAL DOX |
| 240014448 | 240008745 | 1.76 | null | Palliative (P) | 2019-09-08 | 2019-11-02 | Temozolomide 200mg/m2 | N | N | 240013365 | LIPOSOMAL DOXORUBICIN |
| 240014449 | 240015440 | 1.81 | 86.6 | null | 2014-07-01 | 2014-07-01 | CISPLATIN + GEMCITABINE | 02 | N | 240013608 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE |
| 240014450 | 240008747 | 1.66 | 59.7 | Curative (C) | 2018-03-12 | 2018-05-04 | RATHL TRIAL | N | N | 240013846 | CYTARABINE HIGH DOSE |
| 240014451 | 240008749 | null | 67 | Curative (C) | 2014-04-06 | 2014-05-30 | OFATUMUMAB | N | N | 240013888 | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN |
| 240014452 | 240008752 | null | null | Curative (C) | 2017-10-24 | 2017-10-24 | FLAG | N | null | 240014228 | IVE |
| 240014453 | 240008753 | 1.69 | 44.8 | Curative (C) | 2018-07-01 | 2018-07-04 | Carboplatin + Docetaxel | null | N | 240014317 | REMODL TRIAL |
| 240014454 | 240014521 | 1.74 | 57 | Palliative (P) | 2017-03-01 | 2017-05-18 | IMMUNOGLOBULIN | 02 | N | 240014568 | CYCLOPHOSPHAMIDE + VINBLASTINE |
| 240014455 | 240008757 | null | 55.9 | Curative (C) | 2016-12-24 | 2017-03-17 | Carboplatin + Topotecan | N | N | 240014619 | IRINOTECAN + MDG |
| 240014456 | 240008759 | 1.82 | 70 | Palliative (P) | 2017-03-01 | 2017-03-29 | PIXANTRONE | 99 | null | 240014722 | TRIFLURIDINE + TIPIRACIL |
| 240014457 | 240008761 | 1.59 | 50.9 | Palliative (P) | 2017-07-04 | 2017-07-04 | POMALIDOMIDE | 02 | N | 240014781 | ICE |
| 240014458 | 240008764 | 1.8 | 72 | Palliative (P) | 2019-05-11 | 2019-06-12 | Mitoxantrone | 1 | N | 240015091 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB |
| 240014459 | 240008764 | 1.71 | 69 | Neo-adjuvant (N) | 2018-04-14 | 2018-05-08 | Cytarabine High Dose | N | N | 240015091 | CAPECITABINE + OXALIPLATIN |
| 240014460 | 240012682 | 1.74 | 83.4 | Curative (C) | 2016-01-06 | 2016-10-03 | ICE (no GCSF) | 02 | N | 240015306 | ESHAP |
| 240014461 | 240008767 | 1.48 | null | Palliative (P) | 2018-01-02 | 2018-02-23 | FAB LMB | N | N | 240015430 | EC |